High-titer antinuclear antibodies are associated with severe immune-related toxicity and exploratory survival outcomes in advanced gastric cancer immunotherapy
Therapeutic Advances in Medical Oncology
Published online on August 06, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
BackgroundClinicians often screen for autoantibodies before initiating immune checkpoint inhibitors (ICIs) in advanced gastric cancer (GC), yet the utility of organ-specific panels remains unclear.ObjectivesTo evaluate the association of baseline ...
BackgroundClinicians often screen for autoantibodies before initiating immune checkpoint inhibitors (ICIs) in advanced gastric cancer (GC), yet the utility of organ-specific panels remains unclear.ObjectivesTo evaluate the association of baseline ...